VIRGINIA BEACH, VA –March 24, 2015 – Global Enterprises Group, Inc. (OTC-PINK: GLHO) announces the Company has entered into an agreement to acquire a majority position of Predictive Therapeutics, LLC. Appropriate corporate governance changes (i.e., management and board positions) will be made upon completion of the definitive merger agreement, which is expected to be executed within ten days.
About Predictive Therapeutics
Predictive Therapeutics, LLC (“PRx”) was organized to develop, commercialize, acquire and invest in technologies involved in novel molecular diagnostic and therapeutic products in healthcare. PRx intends to revolutionize the treatment of serious, chronic and debilitating diseases through the commercialization of novel therapeutics leveraged by proprietary gene-based companion diagnostics. PRx has developed and/or acquired a pipeline of products. These proprietary technologies can open a window into the origin of human disease and the role that genes and their related proteins play in the disease’s onset and progression. PRx uses genetic information as the cornerstone in the development of new diagnostics that assess a person’s risk of disease and therapeutic products designed to effectively prevent and treat the disease.
About Global Enterprises Group
Headquartered in Virginia Beach, Virginia, Global Enterprises Group operates as a diversified holding company with subsidiaries that operate in infrastructure development, mining, technology development and biotechnology. For further information about this release, contact Rich Kaiser, Investor Relations, YES INTERNATIONAL, #800-631-8127 and/or www.glho.net.
Forward-Looking Statements Disclosure:
This press release may contain “forward-looking statements” within the meaning of the federal securities laws. In this context, forward looking statements may address the Company’s expected future business and financial performance, and often contain words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “seeks,” “will” and other terms with similar meaning. These forward-looking statements by their nature address matters that are, to different degrees, uncertain. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can provide no assurances that these assumptions will prove to be correct. All forward-looking statements in this press release are expressly qualified by such cautionary statements, risk, and uncertainties, and by reference to the underlying assumptions.